AC
TMO icon

Abbrea Capital’s Thermo Fisher Scientific TMO Stock Holding History

Abbrea Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$1.01M Sell
1,820
-212
-10% -$121K 0.13% 117
2024
Q1 		$1.18M Buy
2,032
+70
+4% +$39.3K 0.16% 113
2023
Q4 		$1.04M Sell
1,962
-47
-2% -$22.8K 0.15% 116
2023
Q3 		$1.02M Buy
2,009
+64
+3% +$34.1K 0.16% 108
2023
Q2 		$1.01M Buy
1,945
+432
+29% +$233K 0.16% 117
2023
Q1 		$873K Buy
1,513
+110
+8% +$62K 0.15% 118
2022
Q4 		$773K Sell
1,403
-105
-7% -$55.6K 0.14% 121
2022
Q3 		$765K Sell
1,508
-202
-12% -$113K 0.14% 119
2022
Q2 		$930K Buy
1,710
+79
+5% +$43.5K 0.15% 115
2022
Q1 		$964K Sell
1,631
-350
-18% -$201K 0.14% 118
2021
Q4 		$1.32M Buy
1,981
+316
+19% +$197K 0.18% 99
2021
Q3 		$952K Buy
1,665
+554
+50% +$304K 0.14% 114
2021
Q2 		$561K Buy
1,111
+590
+113% +$278K 0.08% 159
2021
Q1 		$238K Buy
+521
New +$249K 0.04% 212

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Abbrea Capital's TMO Position: Q2 2024 in Review

Abbrea Capital reduced its Thermo Fisher Scientific (TMO) stake by 10% in Q2 2024, selling an estimated $121K and leaving 1,820 shares worth $1.01M. The position accounts for 0.13% of the portfolio, ranked #117.

Abbrea Capital first reported a position in TMO in Q1 2021 and has held it in 14 quarters since. The position peaked at $1.32M in Q4 2021. 2,543 funds tracked by Wall St. Rank hold TMO as of Q2 2024.

  • Abbrea Capital held 1,820 shares of Thermo Fisher Scientific worth $1.01M as of Q2 2024.
  • Abbrea Capital sold 212 Thermo Fisher Scientific shares in Q2 2024, an estimated $121K.
  • Thermo Fisher Scientific made up 0.13% of Abbrea Capital's portfolio in Q2 2024, its #117 holding.
  • Abbrea Capital first reported a position in Thermo Fisher Scientific in Q1 2021 and has held it in 14 quarters since.
  • Abbrea Capital's Thermo Fisher Scientific position peaked at $1.32M in Q4 2021.
  • 2,543 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2024.

Based on Abbrea Capital's 13F filing for Q2 2024, filed 8 Aug 2024.